PMID- 37804602 OWN - NLM STAT- MEDLINE DCOM- 20231023 LR - 20231023 IS - 1568-7856 (Electronic) IS - 1568-7856 (Linking) VI - 131 DP - 2023 Nov TI - Presenilin-1, mutated in familial Alzheimer's disease, maintains genome stability via a gamma-secretase dependent way. PG - 103580 LID - S1568-7864(23)00134-9 [pii] LID - 10.1016/j.dnarep.2023.103580 [doi] AB - Mutations in Presenilin-1 (PS1) account for over 80 % mutations linked to familial Alzheimer's disease (AD). However, the mechanisms of action of PS1 mutations in causing familial AD are not fully understood, limiting opportunities to develop targeted disease-modifying therapies for individuals carrying PS1 mutation. To gain more comprehensive insights into the impact of PS1 mutations on genome stability, we knocked down PS1 in SH-SY5Y, HMC3 and A549 cells. This revealed that PS1 knockdown (KD) dramatically induces genome instability (GIN) in all cell types, as indicated by the increased incidence of micronuclei, nucleoplasmic bridges and/or nuclear buds. Although amyloid beta (Abeta) was able to induce GIN, PS1-KD was associated with decreased expression of Abeta in SH-SY5Y cells, suggesting Abeta is not the primary cause of GIN in PS1-KD cells. In contrast, inhibiting the PS1 gamma-secretase activity by DAPT recapitulated GIN phenotype as seen in PS1-KD cells, indicating that the induction of GIN following PS1 KD can be attributed to the loss of gamma-secretase activity. PS1 KD or gamma-secretase inhibition markedly sensitizes SH-SY5Y to the genotoxicity of mitomycin C. Interestingly, overexpression of the wildtype PS1 dramatically increased GIN in SH-SY5Y. Collectively, our study demonstrates the potential of PS1 and its gamma-secretase activity in maintaining genome stability, highlighting a novel potential link between PS1 loss-of-function or gain-of-function mutations and familial AD through GIN. Several mechanisms by which GIN induced by PS1 dys-expression may contribute to AD are discussed. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Guo, Xihan AU - Guo X AD - School of Life Sciences, Yunnan Normal University, Kunming, Yunnan 650500, China; The Engineering Research Center of Sustainable Development and Utilization of Biomass Energy, Yunnan Normal University, Kunming, Yunnan 650500, China. Electronic address: guo_xihan@163.com. FAU - Jiang, Minyan AU - Jiang M AD - School of Life Sciences, Yunnan Normal University, Kunming, Yunnan 650500, China. FAU - Dai, Xueqin AU - Dai X AD - Academy of Biomedical Engineering, Kunming Medical University, Kunming 650500, China. FAU - Shen, Jie AU - Shen J AD - School of Life Sciences, Yunnan Normal University, Kunming, Yunnan 650500, China. FAU - Wang, Xu AU - Wang X AD - School of Life Sciences, Yunnan Normal University, Kunming, Yunnan 650500, China; The Engineering Research Center of Sustainable Development and Utilization of Biomass Energy, Yunnan Normal University, Kunming, Yunnan 650500, China; Yeda Institute of Gene and Cell Therapy, Taizhou, Zhejiang 318000, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230930 PL - Netherlands TA - DNA Repair (Amst) JT - DNA repair JID - 101139138 RN - EC 3.4.- (Amyloid Precursor Protein Secretases) RN - 0 (Amyloid beta-Peptides) RN - 0 (Presenilin-1) SB - IM MH - Humans MH - *Alzheimer Disease/genetics/metabolism MH - Amyloid Precursor Protein Secretases/genetics/metabolism MH - Amyloid beta-Peptides/genetics/metabolism MH - Presenilin-1/genetics/metabolism MH - *Neuroblastoma MH - Mutation MH - Genomic Instability OTO - NOTNLM OT - Alzheimer's disease OT - Gain-of-function mutation OT - Genome instability OT - Loss-of-function mutation OT - Presenilins COIS- Declaration of Competing Interest The authors state that they no known competing interests. EDAT- 2023/10/08 02:42 MHDA- 2023/10/23 01:18 CRDT- 2023/10/07 18:04 PHST- 2023/05/08 00:00 [received] PHST- 2023/09/26 00:00 [revised] PHST- 2023/09/29 00:00 [accepted] PHST- 2023/10/23 01:18 [medline] PHST- 2023/10/08 02:42 [pubmed] PHST- 2023/10/07 18:04 [entrez] AID - S1568-7864(23)00134-9 [pii] AID - 10.1016/j.dnarep.2023.103580 [doi] PST - ppublish SO - DNA Repair (Amst). 2023 Nov;131:103580. doi: 10.1016/j.dnarep.2023.103580. Epub 2023 Sep 30.